Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,557 | 51,540 | 39,864 | 50,817 | 39,657 |
| Marketable Securities | 228,652 | 188,590 | 235,863 | 263,205 | 164,967 |
| Receivables | 36,451 | 25,126 | 9,303 | 8,175 | 773 |
| Inventories | 7,782 | 8,738 | 7,270 | 5,212 | 715 |
| TOTAL | $338,863 | $281,436 | $303,860 | $334,295 | $208,789 |
| Non-Current Assets | |||||
| PPE Net | 1,209 | 1,075 | 1,075 | 1,029 | 843 |
| Investments And Advances | 13,645 | 13,374 | 11,939 | 5,307 | 0 |
| Intangibles | 14,729 | 12,972 | 7,241 | 7,371 | 7,500 |
| Other Non-Current Assets | 4,357 | 4,615 | 3,203 | 3,151 | 469 |
| TOTAL | $33,940 | $32,036 | $23,458 | $16,858 | $8,812 |
| Total Assets | $372,803 | $313,472 | $327,318 | $351,153 | $217,601 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 49,768 | 44,264 | 27,009 | 22,841 | 16,521 |
| Other current liabilities | 526 | 746 | 540 | 557 | N/A |
| TOTAL | $50,877 | $45,599 | $27,622 | $23,440 | $16,623 |
| Non-Current Liabilities | |||||
| Long Term Debt | 168,273 | 71,959 | 69,383 | 69,383 | N/A |
| Other Non-Current Liabilities | 5,998 | 3,593 | 1,339 | 1,532 | 0 |
| TOTAL | $174,271 | $75,552 | $70,722 | $70,915 | $N/A |
| Total Liabilities | $225,148 | $121,151 | $98,344 | $94,355 | $16,623 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,849 | 98,826 | 98,214 | 98,120 | 97,185 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -253,279 | -202,128 | -157,245 | -123,305 | -173,239 |
| Other shareholders' equity | -7 | -46 | 72 | 220 | 339 |
| TOTAL | $147,655 | $192,321 | $228,974 | $256,798 | $200,978 |
| Total Liabilities And Equity | $372,803 | $313,472 | $327,318 | $351,153 | $217,601 |